Marianna Mancini, Chief Operating Officer at Viking Therapeutics, Inc. (VKTX), sold 36,052 shares at $56.98 ($2.1M) on 2024-07-30, disclosed to the SEC on 2024-07-31.
Open-market sale of $2.1M VKTX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.98 | 14,704 | $838K | 40.7% |
| 2 | $56.98 | 14,704 | $838K | 40.7% |
| 3 | $57.82 | 3,322 | $192K | 9.3% |
| 4 | $57.82 | 3,322 | $192K | 9.3% |
| Total | $57.13 avg | 36,052 | $2.1M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $216K | — | Filing → |
| VKTX | SELL | 2025-07-03 | $237K | — | Filing → |
| VKTX | SELL | 2025-01-06 | $4.4M | — | Filing → |